Elliptic Laboratories AS (ELABS) - Total Liabilities

Latest as of March 2026: Nkr33.36 Million NOK ≈ $3.51 Million USD

Based on the latest financial reports, Elliptic Laboratories AS (ELABS) has total liabilities worth Nkr33.36 Million NOK (≈ $3.51 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Elliptic Laboratories AS (ELABS) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Elliptic Laboratories AS - Total Liabilities Trend (2017–2025)

This chart illustrates how Elliptic Laboratories AS's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Elliptic Laboratories AS.

Elliptic Laboratories AS Competitors by Total Liabilities

The table below lists competitors of Elliptic Laboratories AS ranked by their total liabilities.

Company	Country	Total Liabilities
Credit Clear Ltd AU:CCR	Australia	AU$21.08 Million
Nam Hwa Construction Co.Ltd KQ:091590	Korea	₩22.72 Billion
VirnetX Holding Corp Common Stock NASDAQ:VHC	USA	$7.91 Million
Iskandar Waterfront City Bhd KLSE:1589	Malaysia	RM636.26 Million
Shenzhen SEG Co Ltd SHE:200058	China	HK$2.44 Billion
CTCBIO Inc KQ:060590	Korea	₩77.43 Billion
Cineverse Corp. NASDAQ:CNVS	USA	$86.91 Million
360 Capital Group AU:TGP	Australia	AU$80.96 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Elliptic Laboratories AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Elliptic Laboratories AS balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.68	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Elliptic Laboratories AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Elliptic Laboratories AS (2017–2025)

The table below shows the annual total liabilities of Elliptic Laboratories AS from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	Nkr31.87 Million ≈ $3.35 Million	-10.69%
2024-12-31	Nkr35.69 Million ≈ $3.76 Million	-16.62%
2023-12-31	Nkr42.80 Million ≈ $4.50 Million	+80.57%
2022-12-31	Nkr23.70 Million ≈ $2.49 Million	-17.09%
2021-12-31	Nkr28.59 Million ≈ $3.01 Million	-6.63%
2020-12-31	Nkr30.62 Million ≈ $3.22 Million	-48.40%
2019-12-31	Nkr59.34 Million ≈ $6.24 Million	+8.19%
2018-12-31	Nkr54.84 Million ≈ $5.77 Million	+106.25%
2017-12-31	Nkr26.59 Million ≈ $2.80 Million	--

About Elliptic Laboratories AS

OL:ELABS Norway Software - Infrastructure

Market Cap

$49.72 Million

Nkr472.50 Million NOK

Market Cap Rank

#22002 Global

#199 in Norway

Share Price

Nkr3.74

Change (1 day)

+1.08%

52-Week Range

Nkr2.38 - Nkr10.10

All Time High

Nkr29.05